Statement Of Changes In Equity [Abstract]

ERYTECH Pharma S.A. - Filing #880081

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-12-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-04-01 to 2021-04-30	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	2019-01-01 to 2019-12-31	As at 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	As at 2019-12-31	2019-01-01 to 2019-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	25 293 EUR	—	22 845 EUR	—	—	—	—	—	—	53 797 EUR	97 618 EUR	—	1 215 EUR	3 102 EUR	—	—	—	2 006 EUR	1 744 EUR	24 616 EUR	120 705 EUR	—	26 539 EUR	—	—	—	—	73 300 EUR	—	—	136 607 EUR	1 344 EUR	281 688 EUR	85 560 EUR	—	1 794 EUR	—	—	62 659 EUR	—	99 524 EUR	188,000 EUR	281 744 EUR	145 602 EUR	1 794 EUR	38 224 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	—	—	—	53 797 EUR	—	—	—	—	—	—	—	53 797 EUR	—	73 300 EUR	—	—	—	—	—	—	—	—	—	73 300 EUR	—	—	—	—	—	—	—	62 659 EUR	—	—	62 659 EUR	—	—	—	—	—	—	—	—
Other comprehensive income	—	68,000 EUR	—	—	528,000 EUR	—	—	—	—	—	—	—	—	—	460,000 EUR	—	381,000 EUR	—	—	—	—	19,000 EUR	—	—	400,000 EUR	—	—	—	38,000 EUR	1 237 EUR	—	—	—	—	1 199 EUR	—	—	—	—	—	—	—	—	—	—	—
Comprehensive income	—	68,000 EUR	—	— EUR	528,000 EUR	—	53 797 EUR	—	—	—	—	— EUR	—	—	54 257 EUR	—	72 919 EUR	—	—	—	—	19,000 EUR	—	— EUR	400,000 EUR	— EUR	73 300 EUR	—	38,000 EUR	1 237 EUR	—	—	—	—	61 460 EUR	—	— EUR	62 659 EUR	—	— EUR	—	—	—	—	—	—
Issue of equity	—	—	—	51 746 EUR	—	31 826 EUR	—	6 616 EUR	6 957 EUR	—	—	1 096 EUR	—	—	52 842 EUR	24 867 EUR	12 719 EUR	—	—	—	—	—	—	212,000 EUR	—	12 507 EUR	—	—	—	—	—	—	—	—	— EUR	—	— EUR	—	—	— EUR	—	—	—	—	—	—
Increase (decrease) through other changes, equity	—	195,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	195,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	180,000 EUR	295,000 EUR	—	—	—	—	— EUR	—	—	—	—	115,000 EUR	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	1 323 EUR	—	—	—	—	—	—	—	—	—	—	—	—	1 323 EUR	—	1 179 EUR	—	—	—	—	1 179 EUR	—	—	—	—	—	—	1 359 EUR	—	—	—	—	—	1 359 EUR	—	—	—	—	—	—	—	—	—	—	—